SALL4 as a new biomarker for early colorectal cancers

Journal of Cancer Research and Clinical Oncology

Volumn 141, Issue 2, 2015, Pages 229-235

  Ardalan Khales, Sima ^a   Abbaszadegan, Mohammad Reza ^b   Abdollahi, Abbas ^c   Raeisossadati, Reza ^d   Tousi, Mohsen Fallah ^e   Forghanifard, Mohammad Mahdi ^f  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d UNIVERSIDADE FEDERAL DO ABC   (Brazil)

^e MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

CEA; Colorectal cancer; Prognosis marker; SALL4

Indexed keywords

MESSENGER RNA; SALL4 PROTEIN; STEM CELL FACTOR; UNCLASSIFIED DRUG; CARCINOEMBRYONIC ANTIGEN; SALL4 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR MARKER;

ADULT; ARTICLE; BLOOD; BLOOD SAMPLING; CANCER PATIENT; CANCER SCREENING; CANCER SIZE; COLORECTAL CANCER; CONTROLLED STUDY; COPY NUMBER VARIATION; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; EARLY CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SEX; TUMOR DIFFERENTIATION; TUMOR INVASION; CANCER GRADING; CANCER STAGING; CASE CONTROL STUDY; COLORECTAL NEOPLASMS; COMPARATIVE STUDY; EARLY DIAGNOSIS; FOLLOW UP; GENETICS; LYMPH NODE METASTASIS; MIDDLE AGED; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CARCINOEMBRYONIC ANTIGEN; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; EARLY DIAGNOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; ROC CURVE; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84921065390     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-014-1808-y     Document Type: Article

References (37)

1. Ahmedin Jemal D, PhD1, Freddie Bray P, Melissa M. Center M, Jacques Ferlay M, Elizabeth Ward P, David Forman P. 2011. Global Cancer Statistics. CA Cancer J Clin 61:69–90
2. Al-Baradie R, Yamada K, St Hilaire C, Chan WM, Andrews C, McIntosh N, Nakano M, Martonyi EJ, Raymond WR, Okumura S et al (2002) Duane radial ray syndrome (Okihiro syndrome) maps to 20q13 and results from mutations in SALL4, a new member of the SAL family. Am J Hum Genet 71(5):1195–1199
3. Andersen CL, Jensen JL, Orntoft TF (2004) Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res 64(15):5245–5250
4. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, Guo J, Zhang Y, Chen J, Guo X et al (2008) Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18(10):997–1006
5. De Roock W, Biesmans B, De Schutter J, Tejpar S (2009) Clinical biomarkers in oncology: focus on colorectal cancer. Mol Diagn Ther 13(2):103–114
6. Duffy MJ (2001) Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful? Clin Chem 47:624–630
7. Eleftheriadis N, Papaloukas C, Pistevou-Gompaki K (2009) Diagnostic value of serum tumor markers in asymptomatic individuals. J Buon 14(4):707–710
8. Forghanifard MM, Moghbeli M, Raeisossadati R, Tavassoli A, Mallak AJ, Boroumand-Noughabi S, Abbaszadegan MR (2013) Role of SALL4 in the progression and metastasis of colorectal cancer. J Biomed Sci 20:6
9. Forghanifard MM, Ardalan Khales S, Javdani-Mallak A, Rad A, Farshchian M, Abbaszadegan MR (2014) Stemness state regulators SALL4 and SOX2 are involved in progression and invasiveness of esophageal squamous cell carcinoma. Med Oncol 31(4):922
10. Grutzmann R, Molnar B, Pilarsky C, Habermann JK, Schlag PM, Saeger HD, Miehlke S, Stolz T, Model F, Roblick UJ et al (2008) Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay. PLoS one 3(11):e3759
11. Huang Z, Huang D, Ni S, Peng Z, Sheng W, Du X (2010) Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer 127(1):118–126
12. Itou J, Toi M (2014) Function of the Developmental Transcription Factor SALL4 in Cancer. J Carcinog Mutagen 5(159):2
13. Jain KK (2007) Cancer biomarkers: current issues and future directions. Curr Opin Mol Ther 9(6):563–571
14. Jurgens G (1988) Head and tail development of the Drosophila embryo involves spalt, a novel homeotic gene. EMBO J 7(1):189–196
15. Kanavos P, Schurer W (2009) The dynamics of colorectal cancer management in 17 countries. Eur J Health Econ 10(Suppl 1):S115–S129
16. Kim DH, Pickhardt PJ, Taylor AJ, Leung WK, Winter TC, Hinshaw JL, Gopal DV, Reichelderfer M, Hsu RH, Pfau PR (2007) CT colonography versus colonoscopy for the detection of advanced neoplasia. N Engl J Med 357(14):1403–1412
17. Kim HJ, Yu MH, Kim H, Byun J, Lee C (2008) Noninvasive molecular biomarkers for the detection of colorectal cancer. BMB Rep 41(10):685–692
18. Kohlhase J, Schuh R, Dowe G, Kühnlein RP, Jäckle H, Schroeder B, Schulz-Schaeffer W, Kretzschmar HA, Köhler A, Müller U et al (1996) Isolation, characterization, and organ-specific expression of two novel human zinc finger genes related to the Drosophila gene spalt. Genomics 38:291–298
19. Lee BB, Lee EJ, Jung EH et al (2009) Aberrant methylation of APC, MGMT, RASSF2A, and Wif1 genes in plasma as a biomarker for early detection of colorectal cancer. Clin Cancer Res 15:6185–6191
20. Levin B, Lieberman DA, McFarland B, Andrews KS, Brooks D, Bond J, Dash C, Giardiello FM, Glick S, Johnson D et al (2008) Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 134(5):1570–1595
21. Lim CY, Tam WL, Zhang J, Ang HS, Jia H, Lipovich L, Ng HH, Wei CL, Sung WK, Robson P et al (2008) Sall4 regulates distinct transcription circuitries in different blastocyst-derived stem cell lineages. Cell Stem Cell 3:543–554
22. Mandel JS (2008) Screening for colorectal cancer. Gastroenterol Clin North Am 37(1):97–115
23. Migliore L, Migheli F, Spisni R, Coppede F (2011) Genetics, cytogenetics, and epigenetics of colorectal cancer. J Biomed Biotechnol: 792362
24. Newton KF, Newman W, Hill J (2012) Review of biomarkers in colorectal cancer. Colorectal Dis 14(1):3–17
25. Raeisossadati R, Farshchian M, Ganji A, Tavassoli A, Velayati A, Dadkhah E, Chavoshi S, Bahar MM, Memar B, Rajabi Mashhadi MT et al (2011) Quantitative analysis of TEM-8 and CEA tumor markers indicating free tumor cells in the peripheral blood of colorectal cancer patients. Int J Colorectal Dis 26(10):1265–1270
26. Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative (CT) method. Nat Protoc 3:1101–1108
27. Shuai XZD, Shen T, Wu Y, Zhang J, Wang X, Li Q (2009) Overexpression of the novel oncogene SALL4 and activation of the Wnt/beta-catenin pathway in myelodysplastic syndromes. Cancer Genet Cytogenet 194:119–124
28. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62(1):10–29
29. Siegel R, Desantis C, Jemal A (2014) Colorectal cancer statistics, 2014. CA Cancer J Clin 64(2):104–117
30. Summers T, Langan RC, Nissan A, Brucher BL, Bilchik AJ, Protic M, Daumer M, Avital I, Stojadinovic A (2013) Serum-based DNA methylation biomarkers in colorectal cancer: potential for screening and early detection. J Cancer 4(3):210–216
31. Ueno S, Lu J, He J, Li A, Zhang X, Ritz J, Silberstein LE, Chai L (2014) Aberrant expression of SALL4 in acute B cell lymphoblastic leukemia: Mechanism, function, and implication for a potential novel therapeutic target. Exp Hematol 42(4):307–316
32. Winawer S, Fletcher R, Rex D, Bond J, Burt R, Ferrucci J, Ganiats T, Levin T, Woolf S, Johnson D et al (2003) Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. Gastroenterology 124(2):544–560
33. Xu D, Li XF, Zheng S, Jiang WZ (2006) Quantitative real-time RT-PCR detection for CEA, CK20 and CK19 mRNA in peripheral blood of colorectal cancer patients. J Zhejiang Univ Sci B 7(6):445–451
34. Yang J, Chai L, Fowles TC, Alipio Z, Xu D, Fink LM, Ward DC, Ma Y (2008) Genome-wide analysis reveals Sall4 to be a major regulator of pluripotency in murine-embryonic stem cells. Proc Natl Acad Sci USA 105:19756–19761
35. Yuri S, Fujimura S, Nimura K, Takeda N, Toyooka Y, Fujimura Y, Aburatani H, Ura K, Koseki H, Niwa H et al (2009) Sall4 is essential for stabilization, but not for pluripotency, of embryonic stemcells by repressing aberrant trophectoderm gene expression. Stem Cells 27:796–805
36. Zhang L, Xu Z, Xu X, Zhang B, Wu H, Wang M, Zhang X, Yang T, Cai J, Yan Y et al (2013) SALL4, a novel marker for human gastric carcinogenesis and metastasis. Oncogene. doi:10.1038/onc.2013.495
37. Zieglschmid V, Hollmann C, Bocher O (2005) Detection of disseminated tumor cells in peripheral blood. Crit Rev Clin Lab Sci 42(2):155–196